From Ozempic and Wegovy to social media and the evening news, this naturally occurring hormone has transformed conversations around weight loss, appetite, and blood sugar management
Your liver, pancreas, and metabolic systems are adjusting to triple receptor activation in ways that are not immediately perceptible
Ozempic and Mounjaro are specifically FDA-approved for the treatment of type 2 diabetes, while Wegovy and Zepbound are FDA-approved for chronic weight management
GLP-1 medicines can change how hungry you feel
Clinical data shows tolerability improves with gradual titration and patient education on injection technique and dietary adjustment
Month 2 (weeks 5-8) demands cold foods over hot, BRAT diet during worst days, and aggressive nausea management through strategic meal timing